{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-007933","form_type":"8-K","ticker":"OCEA","cik":"0001869974","company_name":"Ocean Biomedical, Inc.","filed_at":"2025-02-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:05.425928+00:00","generated_at":"2026-05-26T07:13:50.344298+00:00","sec_items":["5.03"],"event_type":"other","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"Ocean Biomedical amends bylaws to set quorum at 1/3 of outstanding shares","bullets":["Amendment changes shareholder meeting quorum from previous level to 1/3 of shares outstanding as of record date.","Board of Directors approved the bylaw amendment on February 14, 2025.","Effective as of February 14, 2025; no other changes to bylaws disclosed.","Company remains an emerging growth company under SEC rules."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-007933","json":"https://secwatch.observer/filing/0001493152-25-007933.json","markdown":"https://secwatch.observer/filing/0001493152-25-007933.md","text":"https://secwatch.observer/filing/0001493152-25-007933.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1869974/000149315225007933/0001493152-25-007933-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1869974/000149315225007933/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-26T07:13:50.344298+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"9337ca0076355dd6283066196403b6ac18d0628f","claim":"Ocean Biomedical, Inc.: On February 14, 2025, Ocean Biomedical, Inc. amended its Bylaws to change the quorum for shareholders meetings to 1/3 of the shares of common stock outstanding on the record date for such meeting (effective 2025-02-14).","evidence_excerpt":"On February 14, 2025, Ocean Biomedical, Inc. (the \"Company\") amended its Bylaws to change the quorum for shareholders meetings to 1/3 of the shares of common stock outstanding on the record date for such meeting.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1869974/000149315225007933/0001493152-25-007933-index.htm","confidence":0.95,"family_label":"Governance Changes","details":[{"label":"Change","value":"bylaw amendment"},{"label":"Effective","value":"2025-02-14"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}